Argomento

Indietro March 2022 - Emerging Infectious Diseases Journal

  

Highlights: Emerging Infectious Diseases, Vol. 28, No. 3, March 2022

The articles of interest summarized below will appear in the March 2022 issue of Emerging Infectious Diseases, CDC’s monthly peer-reviewed public health journal. This issue will feature mycobacterial infections. The articles are embargoed until February 16, 2022, at noon Eastern time.

Important Note: Most articles that EID publishes do not represent work done at CDC or by CDC staff. In your stories, please use our suggested language to clarify whether a study was conducted by CDC (“a CDC study”) or by another institution (“a study published by ____ in the EID journal”). Opinions expressed by authors contributing to EID do not necessarily reflect the opinions of CDC or the institutions with which the authors are affiliated.

Please link directly to the actual journal article in your stories. Once the embargo lifts, this month’s articles will be found in the Early Release section of the EID website.

EID is publishing many articles on the COVID-19 pandemic. Because we publish those articles on an expedited track, and we have no embargo on their content, we do not include them in these monthly press notices. You may wish to subscribe to receive email notifications when EID publishes expedited articles as well as other types of articles.

Note that the most recent EID COVID-19 papers are at the top of the journal’s home page and also included in the Coronavirus Spotlight.

Entire content available on: https://www.cdc.gov/media/eid/2022/03.html



Lingua

Inglese

Tipologia

Articoli scientifici/Reviews Repository

Argomento

Covid-19 Malattie infettive

Profilo

Ospedale/LTCF Salute pubblica Cure primarie

Paese

USA